Home
LIPO
LIPO News

Latest Lipella Pharmaceuticals Inc. (LIPO) News on July 27, 2024

Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus

GlobeNewswire

2 months ago

Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus

Lipella Pharmaceuticals Announces Abstract Publication at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

2 months ago

Lipella Pharmaceuticals Announces Abstract Publication at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Following Guidance from U.S. Food & Drug Administration in Type-C Meeting Lipella Pharmaceuticals to Advance Lead Product Candidate to Phase 2b

GlobeNewswire

2 months ago

Following Guidance from U.S. Food & Drug Administration in Type-C Meeting Lipella Pharmaceuticals to Advance Lead Product Candidate to Phase 2b

Lipella Pharmaceuticals First Quarter 2024 Earnings: US$0.16 loss per share (vs US$0.19 loss in 1Q 2023)

Simply Wall St.

2 months ago

Lipella Pharmaceuticals First Quarter 2024 Earnings: US$0.16 loss per share (vs US$0.19 loss in 1Q 2023)

Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise

GlobeNewswire

3 months ago

Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise

Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024

GlobeNewswire

4 months ago

Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024

Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis

GlobeNewswire

4 months ago

Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis

PRISM MarketView Spotlights Lipella Pharmaceuticals as it Seizes Opportunities in Rare Disease

GlobeNewswire

5 months ago

PRISM MarketView Spotlights Lipella Pharmaceuticals as it Seizes Opportunities in Rare Disease

Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410 for Oral Graft-Versus-Host Disease, Advancing Clinical Pipeline

GlobeNewswire

5 months ago

Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410 for Oral Graft-Versus-Host Disease, Advancing Clinical Pipeline

Lipella Pharmaceuticals Full Year 2023 Earnings: US$0.77 loss per share (vs US$0.64 loss in FY 2022)

Simply Wall St.

5 months ago

Lipella Pharmaceuticals Full Year 2023 Earnings: US$0.77 loss per share (vs US$0.64 loss in FY 2022)

Lipella Pharmaceuticals to Present at PropThink Digital Investor Conference

GlobeNewswire

5 months ago

Lipella Pharmaceuticals to Present at PropThink Digital Investor Conference

CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting Antibody Drug Conjugate Demonstrates Encouraging Safety and Efficacy in Patients with Nectin-4 Positive Tumors in First-In-Human Study Presented at ASCO-GU 2024

GlobeNewswire

6 months ago

CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting Antibody Drug Conjugate Demonstrates Encouraging Safety and Efficacy in Patients with Nectin-4 Positive Tumors in First-In-Human Study Presented at ASCO-GU 2024

SELLAS Life Sciences to Present SLS009 Phase 1 Data from Acute Myeloid Leukemia Patients at the 2024 European School of Haematology (ESH) Conference

GlobeNewswire

6 months ago

SELLAS Life Sciences to Present SLS009 Phase 1 Data from Acute Myeloid Leukemia Patients at the 2024 European School of Haematology (ESH) Conference

Rent the Runway, Inc. (RENT) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

6 months ago

Rent the Runway, Inc. (RENT) Upgraded to Buy: What Does It Mean for the Stock?

Greenwave Technology Solutions Generates More than $9 Million Revenue in Q4 2023

PR Newswire

6 months ago

Greenwave Technology Solutions Generates More than $9 Million Revenue in Q4 2023

Nukkleus Announces Collaboration between DRFQ and Tantel Group to Expand Footprint in Africa

Business Wire

6 months ago

Nukkleus Announces Collaboration between DRFQ and Tantel Group to Expand Footprint in Africa

The Arena Group Announces Workforce Reductions in Strategic Move to Transform the Business Model

Business Wire

6 months ago

The Arena Group Announces Workforce Reductions in Strategic Move to Transform the Business Model

Altisource Asset Management Corporation Repurchases Preferred Shares in Global Settlement With Luxor Capital

Business Wire

6 months ago

Altisource Asset Management Corporation Repurchases Preferred Shares in Global Settlement With Luxor Capital

When Will Aytu BioPharma, Inc. (NASDAQ:AYTU) Become Profitable?

Simply Wall St.

6 months ago

When Will Aytu BioPharma, Inc. (NASDAQ:AYTU) Become Profitable?

Genius Group Announces Pricing of $8.25 Million Public Offering

GlobeNewswire

6 months ago

Genius Group Announces Pricing of $8.25 Million Public Offering

Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India

Business Wire

7 months ago

Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India

Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance

GlobeNewswire

7 months ago

Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance

Aprea Therapeutics Provides Corporate Update and Announces Development Plans for 2024

GlobeNewswire

7 months ago

Aprea Therapeutics Provides Corporate Update and Announces Development Plans for 2024

CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™

Business Wire

7 months ago

CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™

BiomX Receives Orphan Drug Designation from the U.S. Food and Drug Administration for BX004 for the Treatment of Chronic Pulmonary Infection Caused by Pseudomonas aeruginosa in Patients with Cystic Fibrosis

GlobeNewswire

7 months ago

BiomX Receives Orphan Drug Designation from the U.S. Food and Drug Administration for BX004 for the Treatment of Chronic Pulmonary Infection Caused by Pseudomonas aeruginosa in Patients with Cystic Fibrosis

Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro

PR Newswire

7 months ago

Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro

Banzai Announces Premier AI Webinar Host, Demio AI, to Elevate On-Demand Events

GlobeNewswire

7 months ago

Banzai Announces Premier AI Webinar Host, Demio AI, to Elevate On-Demand Events

Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished

GlobeNewswire

7 months ago

Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished

Faraday Future Continues Actions to Protect Stockholders Against Potential Illegal Trading Activities

Business Wire

7 months ago

Faraday Future Continues Actions to Protect Stockholders Against Potential Illegal Trading Activities

Ondas Holdings Inc. (NASDAQ:ONDS) Shares Could Be 32% Above Their Intrinsic Value Estimate

Simply Wall St.

7 months ago

Ondas Holdings Inc. (NASDAQ:ONDS) Shares Could Be 32% Above Their Intrinsic Value Estimate

Fuel Tech Awarded Air Pollution Control and Chemical Technologies Orders Totaling $2.5 Million

Business Wire

7 months ago

Fuel Tech Awarded Air Pollution Control and Chemical Technologies Orders Totaling $2.5 Million

The Arena Group Announces Termination Of CEO Ross Levinsohn, Appoints Manoj Bhargava As Interim CEO

Business Wire

8 months ago

The Arena Group Announces Termination Of CEO Ross Levinsohn, Appoints Manoj Bhargava As Interim CEO

Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106 at the 2023 American Society of Hematology (ASH) Annual Meeting

GlobeNewswire

8 months ago

Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106 at the 2023 American Society of Hematology (ASH) Annual Meeting

Build Better Journalist Relationships with These Three Tips from ACCESSWIRE

ACCESSWIRE

8 months ago

Build Better Journalist Relationships with These Three Tips from ACCESSWIRE

Co-Diagnostics, Inc. to Participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on November 30, 2023

PR Newswire

8 months ago

Co-Diagnostics, Inc. to Participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on November 30, 2023

Carver Bancorp, Inc. Interim CEO Craig C. MacKay Comments on the Bank's Recent Performance

PR Newswire

8 months ago

Carver Bancorp, Inc. Interim CEO Craig C. MacKay Comments on the Bank's Recent Performance

Vroom Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

8 months ago

Vroom Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

8 months ago

Polished.com Announces Results for Third Quarter of 2023 and Amendment of Credit Agreement

Serina Therapeutics Announces POZ Polymer Technology License Agreement with Pfizer

GlobeNewswire

8 months ago

Serina Therapeutics Announces POZ Polymer Technology License Agreement with Pfizer

GlobeNewswire

8 months ago

Interactive Strength Inc. d/b/a FORME Reports Third Quarter 2023 Results

Business Wire

8 months ago

Polished.com Postpones Reporting of Third Quarter 2023 Financial Results

Associated Press Finance

8 months ago

Scynexis: Q3 Earnings Snapshot

SCYNEXIS Reports Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire

8 months ago

SCYNEXIS Reports Third Quarter 2023 Financial Results and Provides Corporate Update

FDA Grants Orphan Designation for Lipella's LP-310 Drug Candidate for Oral Graft-versus-Host Disease

PR Newswire

9 months ago

FDA Grants Orphan Designation for Lipella's LP-310 Drug Candidate for Oral Graft-versus-Host Disease

Business Wire

9 months ago

Polished.com Announces Date for Third Quarter 2023 Earnings Release

Share on Social Networks: